A closer look at “How an Overlooked Immune Cell Killed the Deadliest Lung Cancer in Lab Tests”, exactly as the source publishes it. Scientists may have found an unexpected ally in the fight against small cell lung cancer (SCLC), a disease with a grim 7% five-year survival rate. New lab research shows that a type of immune cell often ignored in cancer studies—gamma delta T cells—can destroy SCLC tumors. The study, conducted by researchers at the University of Texas MD Anderson Cancer Center, found that these cells, which are rare in the blood but common in the lungs, can recognize and kill SCLC cells without prior exposure.
When researchers activated gamma delta T cells in mice with SCLC, the tumors shrank significantly, and some mice were cured. The findings suggest a potential new immunotherapy for a cancer that has seen few treatment advances in decades. The full version stays on the original page, which this listing opens directly.